Technological surveillance in the field of precision medicine is crucial, not only to identify and monitor the most recent advances, but also to evaluate opportunities and challenges in Research, Development and Innovation (R&D&I) processes. Given that precision medicine has direct and significant applications in health, it is imperative that R&D&I processes are carried out with a deep knowledge of the current technological landscape.
The trend in the publication of patents related to precision medicine over the last decade is growing, with positive forecasts in the coming years. This increase in patent publications reflects the growing interest and advancement in the field of precision medicine. Academic publications represent fundamental discoveries that expand knowledge, while patents reflect how this knowledge is translated into practical applications that can transform industries and improve quality of life. In the precision medicine sector we see that the growing trend in academic activity drives technological development, as it presents the same trend.
Most registrations come from the United States, the World Intellectual Property Organization (WIPO), the European Patent Office (EPO) and finally China. Although the geographies with the greatest academic activity in MP are the United States, China and the United Kingdom, there is a tendency to seek protection through WIPO and EPO. Suggesting that innovators seek to secure their inventions in multiple jurisdictions, maximizing the protection of their technologies in key and broad coverage markets. Intellectual property jurisdiction in the United States allows the patenting of drugs and pharmaceutical compounds, encouraging innovation and protection of new therapies. In contrast, WIPO does not oblige member countries to allow patenting of therapeutic methods.
